These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25986619)

  • 61. Stem cells in the aetiopathogenesis and therapy of rheumatic disease.
    Moore J; Tyndall A; Brooks P
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):711-26. PubMed ID: 11812017
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Innate immunity against HIV-1 infection.
    Altfeld M; Gale M
    Nat Immunol; 2015 Jun; 16(6):554-62. PubMed ID: 25988887
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HIV therapeutic vaccines: moving towards a functional cure.
    Mylvaganam GH; Silvestri G; Amara RR
    Curr Opin Immunol; 2015 Aug; 35():1-8. PubMed ID: 25996629
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of host genetic variation on infection with HIV-1.
    McLaren PJ; Carrington M
    Nat Immunol; 2015 Jun; 16(6):577-83. PubMed ID: 25988890
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape.
    Simon V; Bloch N; Landau NR
    Nat Immunol; 2015 Jun; 16(6):546-53. PubMed ID: 25988886
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency.
    Rawlings SA; Alonzo F; Kozhaya L; Torres VJ; Unutmaz D
    PLoS One; 2015; 10(5):e0126917. PubMed ID: 25993666
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Success and failure of the cellular immune response against HIV-1.
    Migueles SA; Connors M
    Nat Immunol; 2015 Jun; 16(6):563-70. PubMed ID: 25988888
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TALEN gene editing takes aim on HIV.
    Benjamin R; Berges BK; Solis-Leal A; Igbinedion O; Strong CL; Schiller MR
    Hum Genet; 2016 Sep; 135(9):1059-70. PubMed ID: 27170155
    [TBL] [Abstract][Full Text] [Related]  

  • 69. De Novo Generated Human Red Blood Cells in Humanized Mice Support Plasmodium falciparum Infection.
    Amaladoss A; Chen Q; Liu M; Dummler SK; Dao M; Suresh S; Chen J; Preiser PR
    PLoS One; 2015; 10(6):e0129825. PubMed ID: 26098918
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells.
    Zhen A; Kamata M; Rezek V; Rick J; Levin B; Kasparian S; Chen IS; Yang OO; Zack JA; Kitchen SG
    Mol Ther; 2015 Aug; 23(8):1358-1367. PubMed ID: 26050990
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multifarious immunotherapeutic approaches to cure HIV-1 infection.
    Imami N; Herasimtschuk AA
    Hum Vaccin Immunother; 2015; 11(9):2287-93. PubMed ID: 26048144
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HIV reservoirs as obstacles and opportunities for an HIV cure.
    Chun TW; Moir S; Fauci AS
    Nat Immunol; 2015 Jun; 16(6):584-9. PubMed ID: 25990814
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review.
    Wilton J; Senn H; Sharma M; Tan DH
    HIV AIDS (Auckl); 2015; 7():125-36. PubMed ID: 25987851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progress and challenges in the use of latent HIV-1 reactivating agents.
    Shang HT; Ding JW; Yu SY; Wu T; Zhang QL; Liang FJ
    Acta Pharmacol Sin; 2015 Aug; 36(8):908-16. PubMed ID: 26027656
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIV integrase inhibitors: a new era in the treatment of HIV.
    Blanco JL; Whitlock G; Milinkovic A; Moyle G
    Expert Opin Pharmacother; 2015 Jun; 16(9):1313-24. PubMed ID: 26001181
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ageing with HIV: a multidisciplinary review.
    Calcagno A; Nozza S; Muss C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G
    Infection; 2015 Oct; 43(5):509-22. PubMed ID: 25987480
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Challenge of a "Functional Cure" for AIDS by Gene Modified HSCT Therapy.
    Xu L; Chen H; Zhang B
    Curr Stem Cell Res Ther; 2015; 10(6):492-8. PubMed ID: 25986619
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS.
    Esmaeilzadeh A; Farshbaf A; Erfanmanesh M
    Med Hypotheses; 2015 Mar; 84(3):216-8. PubMed ID: 25613565
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stem cell-based therapies for HIV/AIDS.
    Pernet O; Yadav SS; An DS
    Adv Drug Deliv Rev; 2016 Aug; 103():187-201. PubMed ID: 27151309
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic modification of hematopoietic stem cells as a therapy for HIV/AIDS.
    Younan P; Kowalski J; Kiem HP
    Viruses; 2013 Nov; 5(12):2946-62. PubMed ID: 24287598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.